Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients
Launched by UNIVERSITAS SEBELAS MARET · Dec 17, 2022
Trial Information
Current as of January 22, 2025
Completed
Keywords
ClinConnect Summary
This research was an observational analytic cohort retrospective study in which the subjects were moderate degree COVID-19 inpatients in Sebelas Maret University Hospital divided into four groups. The control group K0 received standard therapy without NAC, while the treatment group K1 received NAC injections of 1200mg/day, K2 NAC tablets 3x400mg/day, and K3 NAC tablets 3x200mg/day. Different tests using Way ANOVA and LSD or Kruskal-Wallis and Mann-Whitney.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • moderate or severe grade confirmed COVID-19 (patients with symptoms and radiological examination showing pneumonia with or without signs of severe pneumonia: SpO2\<90%, respiratory rate\>30x/min, and severe respiratory distress) who were admitted to UNS Hospital and age 18-60 years old
- Exclusion Criteria:
- • patients who died during the treatment period
About Universitas Sebelas Maret
Universitas Sebelas Maret (UNS) is a prominent educational institution in Indonesia, committed to advancing research and innovation in various fields, including health sciences. With a strong emphasis on clinical research, UNS strives to enhance medical knowledge and improve patient care through rigorous scientific investigation. The university collaborates with multiple stakeholders, including healthcare providers and governmental bodies, to conduct clinical trials that adhere to ethical standards and contribute to global health advancements. UNS is dedicated to fostering a culture of excellence in research, training future healthcare professionals, and addressing pressing health challenges in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sukoharjo, Central Java, Indonesia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials